Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Abnormal tau protein deposition is a hallmark of Alzheimer's disease (AD) pathology.
• The precise mechanisms driving tau accumulation in the brain remain incompletely understood.
• Identifying tau degradation pathways is crucial for understanding AD pathogenesis.

Purpose of the Study:

• To investigate the role of the proteasome in tau protein degradation.
• To determine if tau protein is a substrate for ATP/Mg(2+)-dependent proteolysis.
• To examine the influence of proteasome inhibitors and activators on tau degradation.

Main Methods:

• In vitro co-incubation of rat brain cortex extract with ATP and MgCl(2).
• Assessment of tau degradation using different tau forms (phosphorylated, non-phosphorylated, total).
• Treatment with lactacystin (proteasome inhibitor) and SDS (proteasome activator).
• Analysis of polyubiquitinated tau and degradation of AD brain-derived hyperphosphorylated tau.

Main Results:

• ATP/Mg(2+)-dependent degradation of both phosphorylated and non-phosphorylated tau was observed in vitro.
• Non-phosphorylated tau was more susceptible to proteolysis.
• Degradation was enhanced by SDS and inhibited by lactacystin, with polyubiquitinated tau detected.
• Hyperphosphorylated tau from AD brains was also degraded by the ATP/Mg(2+)-dependent proteasome system.

Conclusions:

• Tau protein, in both phosphorylated and non-phosphorylated forms, is a substrate of the 26S proteasome.
• Tau degradation by the proteasome is an ubiquitin- and ATP-dependent process.
• This study provides direct evidence for proteasomal degradation of tau, offering a potential mechanism for tau clearance in the brain.